What is Phoenix Flow Systems?
Phoenix Flow Systems is a specialized provider of advanced solutions for cell analysis. Their product portfolio includes the APO-BrdU TUNEL assay kit and MultiCycle AV DNA analysis software, which are essential tools for researchers in apoptosis, cell proliferation, and DNA analysis. The company is dedicated to delivering high-quality reagents and software to ensure accurate scientific results, complemented by tailored support for custom configurations and ongoing technical assistance. Their commitment to innovation drives the continuous enhancement of their offerings to meet the evolving demands of the scientific community.
How much funding has Phoenix Flow Systems raised?
Phoenix Flow Systems has raised a total of $92K across 1 funding round:
Debt
$92K
Debt (2021): $92K with participation from PPP
Key Investors in Phoenix Flow Systems
PPP
Public-Private Partnership
What's next for Phoenix Flow Systems?
With significant Series B/C stage funding, Phoenix Flow Systems is poised for accelerated growth and market expansion. The recent capital injection of $92K will likely fuel further research and development into novel cell analysis technologies, potentially broadening their product lines and enhancing existing software capabilities. Strategic investments may also target scaling manufacturing operations and expanding their global sales and distribution networks. This financing round signals strong investor confidence in Phoenix Flow Systems' technology and its potential to capture a larger share of the burgeoning cell analysis market.
See full Phoenix Flow Systems company page
